A citation-based method for searching scientific literature

I M Hramiak, J Dupre, D T Finegood. Diabetes Care 1993
Times Cited: 47







List of co-cited articles
274 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Natural course of remission in IDDM during 1st yr after diagnosis.
S Martin, B Pawlowski, B Greulich, A G Ziegler, T Mandrup-Poulsen, J Mahon. Diabetes Care 1992
81
36

Natural course of insulin resistance in type I diabetes.
H Yki-Järvinen, V A Koivisto. N Engl J Med 1986
290
31







Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
R Bonfanti, E Bazzigaluppi, G Calori, M C Riva, M Viscardi, E Bognetti, F Meschi, E Bosi, G Chiumello, E Bonifacio. Diabet Med 1998
58
17

Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
J J Couper, I Hudson, G A Werther, G L Warne, J M Court, L C Harrison. Diabetes Res Clin Pract 1991
32
25

Residual beta-cell function and spontaneous clinical remission in type 1 diabetes mellitus: the role of puberty.
R Bonfanti, E Bognetti, F Meschi, A Brunelli, M C Riva, M R Pastore, G Calori, G Chiumello. Acta Diabetol 1998
39
20

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
Michael W Steffes, Shalamar Sibley, Melissa Jackson, William Thomas. Diabetes Care 2003
479
17

Factors predicting clinical remission in adult patients with type 1 diabetes.
A Schölin, C Berne, E Schvarcz, F A Karlsson, E Björk. J Intern Med 1999
39
20

Redefining the clinical remission period in children with type 1 diabetes.
H Peter Chase, Todd A MacKenzie, Jonathan Burdick, Rosanna Fiallo-Scharer, Philippe Walravens, Georgeanna Klingensmith, Marian Rewers. Pediatr Diabetes 2004
47
17




Factors predicting course of beta-cell function in IDDM.
A Schiffrin, S Suissa, G Weitzner, P Poussier, D Lalla. Diabetes Care 1992
38
18

New definition for the partial remission period in children and adolescents with type 1 diabetes.
Henrik B Mortensen, Philip Hougaard, Peter Swift, Lars Hansen, Reinhard W Holl, Hilary Hoey, Hilde Bjoerndalen, Carine de Beaufort, Francesco Chiarelli, Thomas Danne,[...]. Diabetes Care 2009
169
14

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.
J Mirouze, J L Selam, T C Pham, E Mendoza, A Orsetti. Diabetologia 1978
161
14

Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
R G Burcelin, M Eddouks, M Beylot, S Normand, C Boitard, G Feutren, P Landais, J P Riou, J R Girard, J F Bach. Diabetes Care 1993
11
54

Postinitial remission in diabetic children--an analysis of 178 cases.
M Knip, A Säkkinen, N P Huttunen, M L Käär, S Länkelä, A Mustonen, H K Akerblom. Acta Paediatr Scand 1982
49
12


Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
P F Bougnères, P Landais, C Boisson, J C Carel, N Frament, C Boitard, J L Chaussain, J F Bach. Diabetes 1990
139
12

Insulin antibodies in insulin-dependent diabetics before insulin treatment.
J P Palmer, C M Asplin, P Clemons, K Lyen, O Tatpati, P K Raghu, T L Paquette. Science 1983
992
12




Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
G Feutren, L Papoz, R Assan, B Vialettes, G Karsenty, P Vexiau, H Du Rostu, M Rodier, J Sirmai, A Lallemand. Lancet 1986
453
12

Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
E Montaña, M Fernandez-Castañer, P Rosel, J Gomez, J Soler. Diabete Metab 1991
13
46

Beta-cell mass and type 1 diabetes: going, going, gone?
Eitan Akirav, Jake A Kushner, Kevan C Herold. Diabetes 2008
109
12

Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
C Giordano, F Pantŏ, M P Amato, N Sapienza, A Pugliese, A Galluzzo. J Autoimmun 1990
10
50

Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
P Pozzilli, N Visalli, M L Boccuni, M G Baroni, R Buzzetti, E Fioriti, A Signore, M G Cavallo, D Andreani, L Lucentini. Diabet Med 1994
30
16

A comparison of childhood and adult type I diabetes mellitus.
J Karjalainen, P Salmela, J Ilonen, H M Surcel, M Knip. N Engl J Med 1989
261
10

Insulin prophylaxis in individuals at high risk of type I diabetes.
R J Keller, G S Eisenbarth, R A Jackson. Lancet 1993
290
10

Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
R Assan, G Feutren, J Sirmai, C Laborie, C Boitard, P Vexiau, H Du Rostu, M Rodier, M Figoni, P Vague. Diabetes 1990
56
10


Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.
S E Kahn, R L Prigeon, D K McCulloch, E J Boyko, R N Bergman, M W Schwartz, J L Neifing, W K Ward, J C Beard, J P Palmer. Diabetes 1993
10

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
C J Greenbaum, D Cuthbertson, J P Krischer. Diabetes 2001
47
10

Prognostic factors for the course of beta cell function in autoimmune diabetes.
C Törn, M Landin-Olsson, A Lernmark, J P Palmer, H J Arnqvist, G Blohmé, F Lithner, B Littorin, L Nyström, B Scherstén,[...]. J Clin Endocrinol Metab 2000
84
10

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
J Silverstein, N Maclaren, W Riley, R Spillar, D Radjenovic, S Johnson. N Engl J Med 1988
239
10

Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
E Böber, B Dündar, A Büyükgebiz. J Pediatr Endocrinol Metab 2001
43
11

Partial remission phase of diabetes in children younger than age 10 years.
B J Muhammad, P G Swift, N T Raymond, J L Botha. Arch Dis Child 1999
44
11

Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.
V A Koivisto, A Aro, K Cantell, M Haataja, J Huttunen, S L Karonen, P Mustajoki, R Pelkonen, P Seppälä. Diabetologia 1984
40
10


Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
E Björk, C Berne, O Kämpe, L Wibell, P Oskarsson, F A Karlsson. Diabetes 1996
97
8

Glucose toxicity.
L Rossetti, A Giaccari, R A DeFronzo. Diabetes Care 1990
798
8


Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.
S Caillat-Zucman, H J Garchon, J Timsit, R Assan, C Boitard, I Djilali-Saiah, P Bougnères, J F Bach. J Clin Invest 1992
272
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.